Perspective Therapeutics, Inc.: Form 10-KT, filed May 1, 2023
Filed with the SEC on May 1, 2023 and accepted by EDGAR at May 1, 2023, 21:03 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 6 months2022-07-01 to 2022-12-31 | $3.6m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 6 months2022-07-01 to 2022-12-31 | $2.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 6 months2022-07-01 to 2022-12-31 | $817.0k | us-gaap:GrossProfit |
| Research and development | 6 months2022-07-01 to 2022-12-31 | $1.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 6 months2022-07-01 to 2022-12-31 | −$7.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 6 months2022-07-01 to 2022-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 6 months2022-07-01 to 2022-12-31 | −$7.3m | us-gaap:NetIncomeLoss |
| Basic EPS | 6 months2022-07-01 to 2022-12-31 | −$0.05 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 6 months2022-07-01 to 2022-12-31 | −$6.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2022-07-01 to 2022-12-31 | $151.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-12-31 | $21.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-31 | $53.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $58.1m | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $2.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-31 | $3.4m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-12-31 | $54.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-23-011946. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.